Objective-Serum sodium concentration is maintained by osmoregulation within normal range of 135 to 145 mmol/L.
C ardiovascular disease (CVD) is a major cause of morbidity and mortality worldwide. 1, 2 Early identification of risk factors/biomarkers is important for timely implementation of preventive measures. Indeed, the identification and control of risk factors, such as elevated blood glucose and cholesterol levels and high blood pressure (BP), have been successful in delaying development of CVDs. 3, 4 
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There is growing evidence that the small differences in plasma sodium between populations might have clinical consequences on health outcomes by directly or indirectly affecting vascular endothelial cells. [5] [6] [7] [8] [9] Epidemiological studies link highsalt intake and conditions predisposing to dehydration, such as low water intake, diabetes mellitus, and old age, to increased risk of CVD. [10] [11] [12] [13] [14] The underlying mechanisms are not fully understood. A common consequence of these conditions is elevation of plasma sodium. 11, [15] [16] [17] [18] [19] We previously demonstrated by multivariable analysis of data from ARIC study (Atherosclerosis Risk in Community) that serum sodium is positively associated with 10-year stroke risk score 6 and with the 10-year coronary heart disease (CHD) risk score. 7 Hypernatremia was associated with significantly increased mortality, largely from CVD, in the British Regional Heart Study. 20 Also, higher levels of plasma sodium starting from 138 mmol/L were associated with higher risk of mortality in a healthy population with big increase of the risk when sodium level exceeded 145 mmol/L. 21 For the current study, we hypothesized that the association we found between serum sodium and 10-year CHD risk score that was retrospectively calculated for ARIC study participants might be because of its association with risk factors that have been identified in epidemiological studies and were used for the CHD risk estimation. 22, 23 Elevated total cholesterol (TC), lowdensity lipoprotein (LDL) cholesterol, and BP are associated with an increased risk of myocardial infarction, stroke, and vascular death and are the main predictors of CHD risk. [22] [23] [24] In the epidemiological studies mentioned above, major cardiovascular pathology occurred in people who had serum sodium outside of the normal range. The main objective of the present analysis was to determine whether there is association of serum sodium with serum lipids and BP even when the sodium is within the normal reference range. The ARIC study is optimal for such analysis because it was started at the time when cholesterol-and BP-lowering medications were not widely used allowing true associations not obscured by ongoing treatments to be revealed. An additional important consideration for selecting subjects for the analysis was the requirement that their sodium concentration be within the normal range of 135 to 145 mmol/L so as to exclude people with ongoing acute or chronic abnormalities of water/salt balance that would obscure true long-term associations of serum sodium with cardiovascular risk factors. After applying these filters, 8615 participants qualified, which is a large enough cohort for comprehensive analysis.
Materials and Methods
We used data from the ARIC study. The data were obtained from the National Heart, Lung and Blood Institute's Biologic Specimen and Data Repository Information Coordinating Center. ARIC is a study of CVD in a cohort of 15 792 45-to 64-year-old black and white men and women sampled from 4 US communities in 1987 to 1989. 25 The plasma lipid measurements analyzed in the present study were LDL cholesterol, TC, high-density lipoprotein (HDL) cholesterol, ratio of TC to HDL cholesterol, and apolipoproteins AI and B. Other measurements included are blood glucose, blood insulin, body mass index (BMI), waist to hip ratio (WHR), and calorie intake. Details of these measurements were reported in ARIC publications. 25, 26 Serum sodium was measured by sodium selective electrode in plus LYTES Option of DACOS Analyzer (Coulter electronics, Inc). Manuals for ARIC plasma lipids, BP, serum sodium, and other measurements can be accessed online (https://www2.cscc.unc.edu/aric/cohort-manuals).
Because BP and lipid levels are the main variables tested for association with serum sodium in our analysis, we excluded participants who took cholesterol-lowering (n=452) and BP-lowering (n=4003) medications. To exclude participants with water/salt balance abnormalities, only those with serum sodium within the normal range (135-145 mmol/L) were included. Hence, 8615 participants remained for analysis.
For analysis of the association of serum sodium with serum lipids and BP, we used data obtained during the baseline examination. Logarithmic transformation of HDL, ratio of TC to HDL cholesterol, and apolipoprotein AI was used to improve the normality of their distributions ( Figure I in the online-only Data Supplement). Multiple regression analysis [27] [28] [29] was used to assess the association of serum sodium with each of the risk factors separately: LDL cholesterol, TC, HDL cholesterol, ratio of TC to HDL cholesterol, apolipoproteins AI and B, and systolic and diastolic BP. Risk factors were treated as dependent variable, and serum sodium level was treated as the predictor variable. Age was included in all regression models as second independent variable as it is a known predictor for the variables analyzed here.
1 Six other confounding factors, blood glucose, insulin, glomerular filtration rate, BMI, WHR, and calorie intake, were also controlled for in some models to detect the serum sodium effect independent of these factors.
Detailed Materials and Methods are available in the online-only Data Supplement.
Results
Positive Association of Serum Sodium and Levels of TC, LDL Cholesterol, TC to HDL Cholesterol Ratio, Apolipoprotein B, and BP
In our previous analysis of data from the ARIC study, we demonstrated that serum sodium concentration during the baseline examination was associated with 10-year CHD risk score 7 and 10-year stroke risk score 6 (the predicted 10-year risk of CHD and stroke calculated for each participant by ARIC investigators, based on the study outcomes 22, 23, 30 ). We hypothesized for the present analysis that sodium might also be associated with some of the risk factors that were used in the calculations. Blood lipid composition and BP are the most prominent factors, after adjustment for age, affecting risk of CHD, 31 and BP is most prominent factor for risk of stroke. 30, 32 Therefore, we examined the relationship between sodium concentration and these risk factors, using multiple linear regressions adjusted for age. Table I in the online-only Data Supplement presents the summary statistics (mean and SD) of the risk factors analyzed and the demographics of the study participants included in the analysis. After exclusions of participants who took BP-and cholesterol-lowering medications and those with serum sodium outside normal range of 135 to 145 mmol/L, 8615 remained for the analysis: 3164 white men, 3691 white women, 739 black men, and 1021 black women. All groups had same average age of 52 years and mean serum sodium concentration of 141 mmol/L.
Multiple regression analysis indicates that TC, LDL cholesterol, TC to HDL cholesterol ratio, and apolipoprotein B, as well as systolic and diastolic BP, are each significantly associated with serum sodium level after adjusting for age (Table 1 ). Figure 1 contains 3-dimensional mesh graphs illustrating this relationship between serum sodium, age, and each of the risk factors. The graphs demonstrate that higher levels of serum sodium at all ages correspond to higher levels of TC (A), LDL cholesterol (B), TC to HDL cholesterol ratio (C), apolipoprotein B (D), systolic BP (E), and diastolic BP (F). An increase of serum sodium from 135 to 145 mmol/L is associated with a 4.2 mm Hg increase in systolic BP (β Na =0.42; 95% confidence interval [CI]=0.25-0.59) and with a 2.5 mm Hg increase of diastolic BP (β Na =0.25; 95% CI=0.15-0.37). A similar increase in systolic BP is associated with a 7-year increase in age (β age =0.62; 95%CI=0.54-0.70). A 10 mmol/L increase in serum sodium is associated with 0.35 mmol/L (13.5 mg/dL) increase in TC (β Na =0.035; 95% CI=0.024-0.045), and a similar increase in cholesterol is associated with a 10-year increase in age (β age =0.035; 95% CI=0.030-0.040). Table II in the online-only Data Supplement indicates that the association between serum sodium and BP after adjustment for age is the most significant for black men (8 mm Hg [β Na =0.80; 95% CI=0.12-1.50] per 10 mmol/L sodium) and lowest for black women (no significant association). Also, the relation between serum sodium and both cholesterol and apolipoprotein B levels is greater for white women than that for white men. Among blacks, there is no significant relation of lipids with serum sodium except for the association of LDL cholesterol with serum sodium in men.
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Having found positive association of blood lipid and of BP with serum sodium ( Figure 1 ; Table 1; Table I in the onlineonly Data Supplement), we then looked for confounders that could be responsible for the observed associations. After adjustment for potential confounders available in ARIC study, such as blood glucose, blood insulin, estimated glomerular Table 1 and Table II in the online-only Data Supplement presenting results of the multivariable regression analysis.
filtration rate, WHR, BMI, and caloric intake, serum sodium remained an independent predictor significantly associated with blood lipid and BP both for the whole analyzed cohort (Table 2 ) and after stratification for race and sex (Table III in the online-only Data Supplement), as well as for smoking status (Table 3) .
Long-Term Stability of Serum Sodium
The ability of serum sodium concentration to serve as a predictor variable for future health outcomes such as CHD 7 and stroke 6 implies that it is stable for long enough to cause longterm effects. Serum sodium was recently proposed to be a long-term characteristic of individuals. 33 The conclusion was based on analysis of plasma sodium over a 10-year interval, using records from two large health plan-based cohorts. The analysis showed that serial plasma sodium values for any given individual tend to cluster around a patient-specific set point and that these set points vary between individuals. 33 To examine the degree of stability of serum sodium among ARIC study participants, we used the 2 serum sodium measurements made 3 years apart in visits 1 and 2 ( Figure 2 ). The significant positive correlation (r=0.36 [95% CI=0.34-0.37]; P<0.0001) between visits 1 and 2 ( Figure 2A) indicates that serum sodium concentration does not vary randomly but is more or less stable in each individual. We also compared the within-individual variance to the between-individual variance of serum sodium measured during the 2 visits. Betweenindividual variance (5.62 mmol/L 2 ) is much higher than the within-individual variance (1.78 mmol/L 2 ), confirming that each individual's serum sodium is relatively stable.
Having confirmed that in individual ARIC study participants serum sodium is stable over the long term, we asked what range of serum sodium concentration the long-term stability occurs over. Analysis of differences in sodium concentration between the 2 visits of each individual demonstrates that for 45% of ARIC participants the difference does not exceed 1 mmol/L, for 65% the difference does not exceed 2 mmol/L, and for 94% the difference does not exceed 3 mmol/L ( Figure 2B ). Variability of serum sodium is lowest in the middle part of the normal range and increases toward lower and higher ends of normal range. For 68% (1 SD), the difference between visits is 2. In our previous analysis of association of serum sodium with 10-year stroke risk score 6 and with the 10-year CHD risk score, 7 participants with sodium levels outside normal range were included. We now checked whether these associations are still present when only people with normal serum sodium levels are included. Analysis shown on Table IV in the onlineonly Data Supplement demonstrates that 10-year risk scores of CHD and stroke are still associated with serum sodium, and this association is eliminated after adjustments for TC and BP. This result suggests the possibility that blood lipids and BP could be the mediating variables for these associations and that serum sodium could potentially serve as preventive target.
Direct Effect of Elevated Extracellular Sodium on Lipid Content of Adipocytes
Having found a cross-sectional association of blood lipids with serum sodium concentration, we then asked whether elevated extracellular sodium might directly affect lipid metabolism. We tested the effect of extracellular sodium on accumulation of lipids in cultured adipocytes (Figure 3 ). After differentiating murine preadipose cells (3T3-L1) into adipocytes, we cultured them in media with sodium concentrations ranging from 135 to 165 mmol/L ( Figure 3A and Materials and Methods section). Measurement of lipid content of the adipocytes throughout the process demonstrated that elevated sodium increases lipid accumulation ( Figure 3B through 3D) . Thus, elevated extracellular sodium directly increases adipocyte lipid content. To get some insight on whether observed effects of elevated sodium is specific to sodium itself or to hypertonicity that it creates, 34 we examined effect of sorbitol on lipid accumulation. Similar to NaCl, elevation of tonicity of cell culture medium by sorbitol increased accumulation of lipids by adipocytes ( Figure II in the online-only Data Supplement), suggesting that increased tonicity rather than specific sodium effects might be responsible for observed changes in lipid metabolism.
Positive Association of Serum Sodium With BMI and WHR in the ARIC Study
The stimulation of lipid content of adipocytes by elevated extracellular sodium (Figure 3) suggested that serum sodium might be associated with BMI and WHR. Indeed, multivariate regression analysis in ARIC data shows positive association of BMI and WHR with serum sodium after adjustment for possible confounders such as age, blood glucose, and calorie intake ( Table 4 ). This result suggests that elevated serum and extracellular sodium concentration even within the normal range may stimulate accumulation of lipids in adipose tissue, leading to increased BMI, WHR, and increased cardiovascular risk. It is worth noting that serum sodium remains a significant predictor of blood lipid level even after adjustment for BMI and WHR (Tables 1 through 3; Table III in the online-only Data Supplement).
Discussion
Sodium (Na + ) and chloride (Cl − ) are the major electrolytes in plasma and extracellular fluids. Their concentration is maintained by osmoregulation within a normal reference range for serum sodium of 135 to 145 mmol/L. 35 Our previous analysis of data from the ARIC study showed that serum sodium was associated with 10-year risk scores of CHD 7 and stroke. 6 In the British Regional Heart Study, hypernatremia was associated with significantly increased mortality, largely from CVD. 20 Also, higher levels of plasma sodium starting from 138 mmol/L were associated with higher risk of mortality in a healthy population with big increase of the risk when sodium level exceeded 145 mmol/L. 21 In attempt to understand possible mechanisms behind these associations, in the present studies, we analyzed association between serum sodium and traditional cardiovascular risk factors, such as serum lipids and BP that are the major contributors for risks of CHD and stroke. 24 In the epidemiological studies mentioned above, major cardiovascular pathology occurred in people who had serum sodium outside of the normal range. To exclude such people in our current analysis, we included only people with sodium concentration within normal range. People who took cholesterol-and BP-lowering medications were also excluded because such ongoing treatments could obscure true associations and decrease the power of the analysis. In this selective cohort, serum sodium was still associated with 10-year risk scores of CHD and stroke (Table IV in the online-only Data Supplement).
Our analysis of the ARIC data in the present study reveals cross-sectional positive association of the traditional risk factors for CVDs, 24 such as TC, LDL cholesterol, TC to HDL cholesterol ratio, apolipoprotein B, and both systolic and diastolic BP with serum sodium. Serum sodium was a significant predictor variable for them when adjusting only for age ( Figure 1 ; Table 1; Table II in the online-only Data Supplement). It remained a significant predictor after further adjusting for multiple possible confounders such as blood glucose, blood insulin, estimated glomerular filtration rate, BMI, WHR, and calorie intake (Table 2) , as well as after stratification based on race and sex (Table III in the online-only Data Supplement) or smoking status (Table 3 ). Blood lipids and BP are major contributors to the pathogenesis of atherosclerosis, 36, 37 which is the underlying cause of the majority of cardiovascular events. Atherosclerosis and accumulation of plaques are lifelong processes that start early in life. TC and LDL cholesterol, BP, and atherosclerosis gradually increase with age 1 until they are high enough to cause clinically evident CVDs. This makes age, itself, a strong risk factor for CVDs. 38 Our regression analysis reveals that 10 mmol/L higher serum sodium, which is within the normal range, increases plasma lipids and BP as much as 7 to 10 years of aging (Table 1) .
Consistent with the possibility that higher serum sodium is a cardiovascular risk factor even within normal range that allows only 10 mmol/L variation, our analysis demonstrates that serum sodium is stable over long times in ARIC study participants (Figure 2 ), which is necessary if it is to serve as a predictor of future health outcomes such as CHD, stroke, and overall mortality. 6, 7, 20, 21 Specifically, our analysis of 2 sodium measurements taken 3 years apart in the ARIC study shows that a majority of people maintain serum sodium concentration that is stable within 2 mmol/L (Figure 2 ). Such narrow range of sodium stability indicates that even within normal range people have opportunity to shift their serum sodium level by simple modifications of water/salt intake, leading to changes in hydration status.
A major goal in fighting CVDs is finding modifiable factors that can delay the progression of preclinical atherosclerosis. Identification of high cholesterol and high BP as cardiovascular risk factors and their control by BP-and cholesterol-lowering medications have succeeded in delaying development of CVDs. 3, 4, 39 Our data imply that decreasing plasma sodium concentration even within normal range might also decrease risk of CVDs through its effects on blood lipid level and BP. A limitation of cross-sectional analysis is that such analysis cannot by itself prove a causative effect of sodium on dependent variables. However, the data presented in Figure 3 show that elevation of extracellular sodium increases lipids in cultured adipocytes, indicating that extracellular sodium can serve as direct modulator of lipid metabolism. In addition, data accumulating in recent years indicate that elevated extracellular sodium has direct proinflammatory, 5, 7 prothrombotic, 6 and stiffening 8 effects on the vascular endothelium, which could be involved in the associations revealed in the current study. Because endothelial activation leads to the release of coagulation and inflammation mediators, contributing to the pathophysiology of atherosclerosis, 40, 41 further studies of those mechanisms could help understand the associations found in the epidemiological studies.
The adverse cardiovascular effects of elevated extracellular sodium might potentially be related to the fact that sodium is a functionally impermeant solute, meaning that elevation of extracellular sodium is hypertonic. High sodium causes osmotic efflux of water from cells, leading to decreased cell volume and increased intracellular ionic strength. Adaptive cellular responses are activated to compensate for the dehydration and its consequences by the transcription factor nuclear factor of activated T cells 5 (NFAT5), which is activated by hypertonicity. Hypertonicity increases the expression of NFAT5 mRNA and protein, increases NFAT5 transcriptional activity, and mediates transcription of many NFAT5 target genes that are directly or indirectly involved in adaptation to high NaCl. 34, 42 The expression of NFAT5 increases from mild water restriction that increases plasma sodium by as little as 5 mmol/L. 6 Moreover, activated NFAT5 binds to the promoter of the vWF (von Willebrand factor) gene, suggesting that it may be involved in the prothrombotic effects of increased extracellular sodium. 6 Consistent with a proatherogenic effect of NFAT5, development of atherosclerosis is delayed in NFAT5 +/− ApoE −/− mice. 43 Furthermore, NFAT5 increases in skin macrophages when high-salt intake leads to sodium accumulation in the skin and is implicated in promotion of lymphatic growth and induction of salt-sensitive hypertension. 44, 45 Accelerated lipid accumulation in cultured adipocytes by both elevated sodium and sorbitol shown in this study ( Figure II in the online-only Data Supplement) suggests that hypertonicity-induced NFAT5 signaling might be involved in regulation of lipid metabolism. More studies are needed to further elucidate the role of NFAT5 in the effects of elevated serum sodium on CVDs.
Serum sodium concentration is affected by water/salt balance and is an indicator of overall hydration. Factors affecting plasma sodium concentration also include, for example, diabetes mellitus and aging. Thus, both diabetes mellitus and aging predispose to dehydration, leading to increased plasma sodium concentration, 15, 16, 18, 19 and both of them increase risk of CVDs, 38, 46 again consistent with involvement of higher plasma sodium as a risk factor for CVD. In addition to direct effects of elevated sodium and resultant hypertonicity outlined above, other indirect factors could mediate associations detected in current study. For example, levels of AVP (arginine vasopressin) increases proportionally with extracellular osmolality, and recent studies are finding positive associations of AVP marker copeptin with increased risks of CVDs. [47] [48] [49] Deciphering the mechanisms involved may help identify new risk factors more proximal to the initial causes and help develop preventive measures and target-specific therapies. 50 Lifestyle-dependent factors affecting serum sodium concentration include the balance between water intake and excretion, affecting the general level of hydration, 16, 51 as well as salt intake. 17, 52, 53 Therefore, simple modification of water and salt consumption sufficient to lower plasma sodium could lower serum lipids and BP and, thus, the rate of development of atherosclerosis and the longterm risk of CVDs.
Perspectives
Usually little attention is paid to variation of serum sodium within its normal range. The associations found in the current study between traditional cardiovascular risk factors and serum sodium that exists even within the normal range suggest that it could be beneficial for everybody's long-term health to shift serum sodium to the lower end of that range. Water and salt intake are the obvious variables, but recommendations for regulating them have not sufficed, so knowledge of additional measures could be helpful. Plasma sodium concentration is rarely analyzed in epidemiological studies of normal subjects, even when effects of salt and water intake are investigated, probably because of its narrow normal range and lack of belief that variation within that range matters. Our analysis, however, demonstrates that plasma sodium is stable in individuals within 2 to 3 mmol/L over long time periods and is positively associated with cardiovascular risk factors even within normal range of 135 to 145 mmol/L. Thus, including an analysis of serum sodium concentration in epidemiological studies of cardiovascular effects of water and salt intake could facilitate interpretation of the results and help better understand how water-salt intake and their balance affect CVD.
